Metraipolis › archive › dc_4f48abe741d5

Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC) — Europe PMC PMID:37233729

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37233729
DOI
10.7554/elife.86014
License (as archived)
CC0-1.0
Archived
2026-10-07T13:26:34.289Z
SHA-256 of the archived text
2da8a80260fcf755c43226cde8b525d7b42005446b39f016b3b12ff2ea29f1ad
Stable URL of this page
https://metraipolis.com/documento/dc_4f48abe741d5

How to cite

Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC) — Europe PMC PMID:37233729 — Europe PMC (en), https://europepmc.org/article/MED/37233729 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_4f48abe741d5 (Metraipolis archive dc_4f48abe741d5, sha256 2da8a80260fcf755c43226cde8b525d7b42005446b39f016b3b12ff2ea29f1ad)
BibTeX
@misc{dc4f48abe741d5,
  title = {Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC) — Europe PMC PMID:37233729},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37233729},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_4f48abe741d5; sha256 2da8a80260fcf755c43226cde8b525d7b42005446b39f016b3b12ff2ea29f1ad},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/37233729. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

With a global tally of more than 500 million cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections to date, there are growing concerns about the post-acute sequelae of SARS-CoV-2 infection (PASC), also known as long COVID. Recent studies suggest that exaggerated immune responses are key determinants of the severity and outcomes of the initial SARS-CoV-2 infection as well as subsequent PASC. The complexity of the innate and adaptive immune responses in the acute and post-acute period requires in-depth mechanistic analyses to identify specific molecular signals as well as specific immune cell populations which promote PASC pathogenesis. In this review, we examine the current literature on mechanisms of immune dysregulation in severe COVID-19 and the limited emerging data on the immunopathology of PASC. While the acute and post-acute phases may share some parallel mechanisms of immunopathology, it is likely that PASC immunopathology is quite distinct and heterogeneous, thus requiring large-scale longitudinal analyses in patients with and without PASC after an acute SARS-CoV-2 infection. By outlining the knowledge gaps in the immunopathology of PASC, we hope to provide avenues for novel research directions that will ultimately lead to precision therapies which restore healthy immune function in PASC patients.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: eLife, 2023 (prima pubblicazione 2023-05-26).
Identificativi: PMID 37233729 · PMCID PMC10219649 · DOI 10.7554/elife.86014.
Parole chiave degli autori: Inflammation; immunology; innate immunity; adaptive immunity; Immunopathology; Pasc; Covid-19.
Descrittori MeSH principali: COVID-19; Post-Acute COVID-19 Syndrome.
Pagina: https://europepmc.org/article/MED/37233729 — https://doi.org/10.7554/elife.86014. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T12:57:59.440Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.